Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Methods Compared for Detection of Fecal Giardiasis

By LabMedica International staff writers
Posted on 27 Mar 2016
Microscopy for intestinal protozoa after formol-ether (FE) or formol-ethylacetate (FEA) concentration is standard procedure for investigating patients with diarrhea where a protozoan etiology is suspected. More...


In recent times, polymerase chain reaction (PCR) or fluorescence-labeled parasite-specific antibodies have been introduced for infections with intestinal protozoan parasites like Giardia duodenalis (syn. G. intestinalis and G. lamblia), Cryptosporidium but their place in everyday routine diagnostics has not yet been established.

Scientists at Aarhus University Hospital (Denmark) compared FEA and salt–sugar flotation (SSF) concentration followed by microscopy of iodine-stained concentrate and immunofluorescence assay (IFA) and real-time polymerase chain reaction (qPCR) for detection of Giardia duodenalis in human feces. Consecutive 455 fecal samples received between August 2012 and April 2013 at the hospital were included. FEA was performed within 48 hours after receipt of the samples. The samples were kept at + 4 °C for up to 90 days prior to qPCR analysis.

Immunofluorescence assays were performed on diluted feces after proper mixing, and a direct smear was made on Teflon coated slides containing three wells of 10 mm (Menzel Gläser, Braunschweig, Germany). The smears were left to air dry at room temperature overnight stained with FITC-labeled anti-Giardia antibodies (Cellabs; Brookvale Australia). Real-time polymerase chain reactions (qPCR) were performed where the crossing point-PCR-cycle (Cp) is the value given by the LightCycler 480 (Roche Diagnostics; Mannheim, Germany) and is similar to cycle threshold (Ct). It is the cycle at which fluorescence achieves a defined threshold.

The median number of Giardia cysts found by FEA in 19 Giardia-positive samples was 50 cysts per gram (CPG), by SSF 350 CPG, by IFA 76,700 CPG, and by qPCR 316,000 CPG. The team next tested 455 consecutive samples for presence of Giardia cysts. Using IFA as reference, qPCR had a sensitivity of 91%, specificity of 95.1%, a false-positive rate of 50%, a false-negative rate of 0.48%, a positive predictive value of 50%, and a negative predictive value of 99.5%.

The authors concluded that qPCR and IFA were significantly more sensitive than microscopy of iodine-stained concentrates using either FEA or SSF. They suggest, when using qPCR, that positive samples are verified by IFA to prevent false-positive results. The study was published in the March 2016 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Aarhus University Hospital
Menzel Gläser 
Cellabs 



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.